Literature DB >> 16082207

The first 30 minutes in the life of a virus: unREST in the nucleus.

Bernard Roizman1, Haidong Gu, Gail Mandel.   

Abstract

On entry of viral DNA into cells, a competition ensues between cellular factors that silence viral genes and transcriptional factors that block silencing and transcribe the DNA. In the case of herpes simplex virus 1, the first set of genes expressed after infection-are induced by a viral protein (alphaTIF or VP16). Expression of later (beta,gamma) genes in cells infected at low ratios of virus per cells requires a transcriptional activator (ICP4) that cannot block silencing and a protein, ICP0, hitherto characterized as a promiscuous transactivator. Recent studies indicate that ICP0 blocks silencing of viral DNA by dissociating HDACs 1 and 2 from the CoREST/REST repressor complex. HDACs 1/2 are phosphorylated and translocated to the nucleus. The findings have broad implications regarding silencing of the viral genome during latency and, potentially, the expression of genes encoded by other DNA viruses as well.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082207     DOI: 10.4161/cc.4.8.1902

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  36 in total

1.  Herpes simplex virus immediate-early protein ICP0 is targeted by SIAH-1 for proteasomal degradation.

Authors:  Claus-Henning Nagel; Nina Albrecht; Kristijana Milovic-Holm; Lakshmikanth Mariyanna; Britta Keyser; Bettina Abel; Britta Weseloh; Thomas G Hofmann; Martha M Eibl; Joachim Hauber
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  VP16 serine 375 is a critical determinant of herpes simplex virus exit from latency in vivo.

Authors:  Nancy M Sawtell; Steven J Triezenberg; Richard L Thompson
Journal:  J Neurovirol       Date:  2011-12-06       Impact factor: 2.643

3.  Reversal of heterochromatic silencing of quiescent herpes simplex virus type 1 by ICP0.

Authors:  Michael W Ferenczy; Neal A DeLuca
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

4.  Evidence that the herpes simplex virus type 1 ICP0 protein does not initiate reactivation from latency in vivo.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

5.  ICP0 and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression.

Authors:  Alice P W Poon; Haidong Gu; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

6.  Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3.

Authors:  Te Du; Guoying Zhou; Bernard Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-20       Impact factor: 11.205

7.  Biogenesis of Extracellular Vesicles during Herpes Simplex Virus 1 Infection: Role of the CD63 Tetraspanin.

Authors:  Christos Dogrammatzis; Thibaut Deschamps; Maria Kalamvoki
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

8.  ICP0 is not required for efficient stress-induced reactivation of herpes simplex virus type 1 from cultured quiescently infected neuronal cells.

Authors:  Craig S Miller; Robert J Danaher; Robert J Jacob
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses.

Authors:  Patrick Paladino; Susan E Collins; Karen L Mossman
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

10.  ICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 gene.

Authors:  Mingyu Liu; Brandon Rakowski; Edward Gershburg; Carla M Weisend; Olivier Lucas; Edward E Schmidt; William P Halford
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.